Navigation Links
Clarient Announces Fourth Quarter and Year-End 2007 Financial Results
Date:3/31/2008

rter of 2006. Our 10 percent sequential growth in test volume versus third quarter is again indicative of our solid trajectory and has provided a strong foundation for continued growth in 2008. We believe that our revenues for the first quarter of 2008 will exceed our revenues for the comparable period in 2007 by more than 50 percent. This base business momentum, combined with the pending launch of Clarient's Insight(TM) Dx Breast Cancer Profile, provides solid reasons to remain very encouraged with our direction. Assuming we maintain our current commercial velocity, we believe we will be able to achieve our 2008 goals of growing revenue between 30-40 percent this year versus the fiscal year ended December 31, 2007."

Total operating expenses were $9.6 million for the fourth quarter of 2007, an increase of 49 percent compared to $6.4 million in the fourth quarter of 2006. The growth in expense was primarily due to increased professional fees, selling expenses and collection expenses. Also the Company recorded bad debt expense and increased its allowance for doubtful accounts by $1.8 million in the fourth quarter of 2007 (as compared to bad debt expense of $300,000 in the fourth quarter of 2006) based on an analysis of its most recent historical collection information.

Operating loss was $3.2 million for the fourth quarter of 2007, an increase of 14 percent from the same period in 2006. Loss from continuing operations in the fourth quarter of 2007 was $3.8 million or $0.05 loss per share, compared to $3.2 million or $0.05 loss per share in the fourth quarter of 2006, an increase of 19 percent.

At December 31, 2007, the Company's cash and cash equivalents were $1.5 million compared to $0.4 million at December 31, 2006. As previously reported, on March 14, 2008 the Company entered into a credit facility with affiliates of Safeguard Scientifics, Inc. pursuant to which Safeguard has agreed to provide the Company with a total of up to $21 million (subj
'/>"/>

SOURCE Clarient, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Clarient CEO Ron Andrews to Participate in OneMedPlace Emerging Healthcare Technologies Finance Forum
2. Clarient to Commercialize Novel Breast Cancer Profile
3. CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
4. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
5. YM BIOSCIENCES ANNOUNCES COMPLIANCE WITH AIM RULE 26
6. Emisphere Technologies, Inc. Announces Pricing of Registered Direct Offering
7. BioLife Solutions Announces Exclusive CryoStor(TM) Supply Agreement With the New England Cryogenic Center, Inc.
8. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
9. China Kangtai Cactus Biotech Files 2nd Quarter 2007 10QSB and Announces Unaudited Quarterly Results
10. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
11. Advanced Life Sciences Announces Receipt of Nasdaq Staff Letter
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/22/2015)... (PRWEB) January 22, 2015 Pipette.com has ... to their comprehensive portfolio of Eppendorf products. , ... to purchase a Centrifuge 5424/5424 R and receive the ... either Eppendorf Research plus or Eppendorf Reference 2 ...
(Date:1/22/2015)... Dr. Greg Leyer of UAS Labs recently was invited to ... on probiotics in San Diego, CA. , The Scripps ... health care professionals. This year’s pre-conference seminar was held on ... Dr. Leyer spoke about the emerging topics and science in ...
(Date:1/22/2015)... Switzerland (PRWEB) January 22, 2015 Selexis ... characterized mammalian Research Cell Banks (RCBs) used for drug ... Research Cell Banks will include Next-Generation Sequencing ... genetic architecture de-risks biologic manufacturing by ensuring the integrity ...
(Date:1/22/2015)... NEW BRUNSWICK , Nueva Jersey , 22 ... Award for Biomedical Research abre hoy su llamada ... las personas cuya investigación científica ha hecho, o tiene ... de la salud humana. Las nominaciones se aceptarán hasta ...
Breaking Biology Technology:Eppendorf Announces Promotional Bundle Which Includes: Eppendorf Centrifuge 5424, 3-Pack of Pipettes, and Tips - Available Now at Pipette.com 2Selexis Generated Research Cell Banks Now Fully Sequenced Using Next-Generation Sequencing 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 2El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 3El Dr. Paul Janssen Award for Biomedical Research emite su llamada a los nominados para 2015 4
... With a 150 year expertise in the genetic improvement ... globally focused outlook, New Zealand,s biotech industry is well ... products. Led by industry organization NZBIO and New Zealand ... are showcasing their capabilities in human health care, animal ...
... 27, 2011 A radiologic technology, which functions like a ... less radiation, is being used to treat patients with symptomatic ... of interventional radiology, is treating patients as part of a ... by Dr. Gupta, allows procedures to be done with more ...
... 27, 2011 Amicus Therapeutics (Nasdaq: FOLD ... therapies for rare diseases, today announced that it has ... small-cap Russell 2000® Indexes. The Company joined the indexes ... 2011, when Russell Investments reconstituted its U.S. and global ...
Cached Biology Technology:New Zealand Brings Its Global "Game Plan" to the 2011 BIO International Convention 2Paoli Hospital Pioneers New Treatment for Uterine Fibroids and Malformations 2Amicus Therapeutics Joins Russell 3000® Index 2
(Date:12/17/2014)... Dec. 15, 2014  HITLAB SM announced today its ... confirm its adherence to current U.S. Food and Drug ... regulated smart device and smart phone application trials utilizing ... "HITLAB is determined to improve global healthcare ...
(Date:12/17/2014)... , Dec. 16, 2014  Automation is fundamentally transforming ... than at international borders. Over the past decade, ePassports, ... travelers to self process through border control via eGates ... number of airports, seaports, and land borders across the ...
(Date:12/11/2014)... Dec. 09, 2014 Research and Markets ... http://www.researchandmarkets.com/research/9ql3kr/biometrics_market ) has announced the addition of the ... offering. One major trend emerging in ... Multimodal biometric systems utilize more than one characteristic of ...
Breaking Biology News(10 mins):HITLAB Completes GCP Audit for FDA Smart Device & App Compliance 2Automated Border Control (ABC) Transforms the Global Travel Experience With More Than 2500 ABC eGates and APC Kiosks Deployed In Airports, Seaports, and Land Borders Worldwide 2Biometrics Market in India 2015-2019: Key Vendors are 3M Cogent, NEC, Safran and Suprema 2
... and NEW YORK, NY Research that used mitochondrial DNA-based ... black caviar purchased before and after international protection shows ... for Conservation Science at Stony Brook University and the ... of Natural History (AMNH) repeated a market survey of ...
... University] In the powerful sunlight of July, newly published ... for basal cell carcinoma support the emerging view of the ... repeatedly afflicts older people but for which the seeds may ... association with eczema. "Basal cell carcinoma is a chronic ...
... 16- 17, 2012, the So Paulo Research Foundation (FAPESP) ... host a workshop to discuss the results of the ... for Managing the Risks of Extreme Events and Disasters ... Central America. The event will be held in So ...
Cached Biology News: International regulation curbs illegal trade of caviar 2 International regulation curbs illegal trade of caviar 3Basal cell carcinoma risk can be chronic 2FAPESP hosts meeting to discuss IPCC SREX report in São Paulo, Brazil 2FAPESP hosts meeting to discuss IPCC SREX report in São Paulo, Brazil 3
Immunogen: Extract of pigmented melanoma metastases from lymph nodes. Storage: -20 C, Avoid Freeze/Thaw Cycles...
... to Human CD66 acd Recognizes ... human neutrophils and cells in some ... reacts with transfectants containing BGPa, NCA ... members(2). Immunogen: ...
This STAT antibody sampler pack contains 8 monoclonal ,STAT antibodies....
Request Info...
Biology Products: